Human Synovia Contains Trefoil Factor Family (TFF) Peptides 1-3 Although Synovial Membrane Only Produces TFF3: Implications in Osteoarthritis and Rheumatoid Arthritis.
Adult
Aged
Aged, 80 and over
Arthritis, Rheumatoid
/ metabolism
Female
Humans
Male
Middle Aged
Osteoarthritis
/ metabolism
Peptides
/ metabolism
RNA, Messenger
/ genetics
Synovial Fluid
/ metabolism
Synovial Membrane
/ metabolism
Tissue Donors
Trefoil Factor-1
/ genetics
Trefoil Factor-2
/ genetics
Trefoil Factor-3
/ genetics
osteoarthritis (OA)
rheumatoid arthritis (RA)
synovial fluid (SF)
synovial membrane (SM)
trefoil factor family peptides (TFF)
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
03 Dec 2019
03 Dec 2019
Historique:
received:
11
11
2019
revised:
27
11
2019
accepted:
28
11
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
17
4
2020
Statut:
epublish
Résumé
Trefoil factor family peptide 3 (TFF3) has been shown to support catabolic functions in cases of osteoarthritis (OA). As in joint physiology and diseases such as OA, the synovial membrane (SM) of the joint capsule also plays a central role. We analyze the ability of SM to produce TFF compare healthy SM and its secretion product synovial fluid (SF) with SM and SF from patients suffering from OA or rheumatoid arthritis (RA). Real-time PCR and ELISA were used to measure the expression of TFFs in healthy SM and SM from patients suffering from OA or RA. For tissue localization, we investigated TFF1-3 in differently aged human SM of healthy donors by means of immunohistochemistry, real-time PCR and Western blot. Only TFF3 but not TFF1 and -2 was expressed in SM from healthy donors as well as cases of OA or RA on protein and mRNA level. In contrast, all three TFFs were detected in all samples of SF on the protein level. No significant changes were observed for TFF1 at all. TFF2 was significantly upregulated in RA samples in comparison to OA samples. TFF3 protein was significantly downregulated in OA samples in comparison to healthy samples and cases of RA significantly upregulated compared to OA. In contrast, in SM TFF3 protein was not significantly regulated. The data demonstrate the production of TFF3 in SM. Unexpectedly, SF contains all three known TFF peptides. As neither articular cartilage nor SM produce TFF1 and TFF2, we speculate that these originate with high probability from blood serum.
Identifiants
pubmed: 31817054
pii: ijms20236105
doi: 10.3390/ijms20236105
pmc: PMC6928748
pii:
doi:
Substances chimiques
Peptides
0
RNA, Messenger
0
Trefoil Factor-1
0
Trefoil Factor-2
0
Trefoil Factor-3
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Histochem Cytochem. 2007 May;55(5):505-13
pubmed: 17242463
Eur J Clin Invest. 2002 Jul;32(7):519-27
pubmed: 12153553
Arthritis Rheum. 2008 Jan;58(1):46-52
pubmed: 18163520
J Rheumatol. 1997 Feb;24(2):365-71
pubmed: 9034998
PLoS One. 2017 Mar 29;12(3):e0174551
pubmed: 28355260
Nat Rev Mol Cell Biol. 2003 Sep;4(9):721-32
pubmed: 14506475
Wiley Interdiscip Rev Syst Biol Med. 2012 Jan-Feb;4(1):15-37
pubmed: 21826801
J Med Chem. 2009 Nov 12;52(21):6505-10
pubmed: 19888754
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7312-23
pubmed: 26559477
PLoS One. 2017 Oct 13;12(10):e0185200
pubmed: 29028798
Cell Mol Life Sci. 2004 Aug;61(15):1946-54
pubmed: 15289936
Clin Chem. 2005 May;51(5):830-8
pubmed: 15718486
Nature. 2003 May 15;423(6937):356-61
pubmed: 12748655
Expert Opin Biol Ther. 2001 Sep;1(5):817-29
pubmed: 11728217
Scand J Clin Lab Invest. 2004 Apr;64(2):146-56
pubmed: 15115253
Clin Respir J. 2015 Jul;9(3):322-9
pubmed: 24720774
Arthritis Res. 2000;2(5):361-7
pubmed: 11094449
N Engl J Med. 2011 Dec 8;365(23):2205-19
pubmed: 22150039
Acta Histochem. 2013 Apr;115(3):204-8
pubmed: 22818426
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):799-804
pubmed: 10639160
Arch Histol Cytol. 2000 Mar;63(1):17-31
pubmed: 10770586
J Rheumatol. 2000 Mar;27(3):594-600
pubmed: 10743795
Hum Immunol. 2011 Mar;72(3):241-8
pubmed: 21195737
Mediators Inflamm. 2014;2014:561459
pubmed: 24876674
Br J Rheumatol. 1995 Jan;34(1):13-23
pubmed: 7881832
Cell Mol Life Sci. 2009 Apr;66(8):1350-69
pubmed: 19099184
Peptides. 2004 May;25(5):727-30
pubmed: 15177865
J Periodontol. 2012 Sep;83(9):1129-38
pubmed: 22181686
BMC Gastroenterol. 2014 Apr 11;14:74
pubmed: 24720760
FEBS Lett. 1999 Jul 30;456(1):155-9
pubmed: 10452549
Osteoarthritis Cartilage. 2012 Dec;20(12):1484-99
pubmed: 22960092
PLoS One. 2013 Nov 25;8(11):e80271
pubmed: 24282531
Arthritis Rheum. 2001 Jun;44(6):1237-47
pubmed: 11407681
J Clin Invest. 1940 Nov;19(6):795-9
pubmed: 16694795
Arthritis Rheum. 2010 Mar;62(3):815-25
pubmed: 20131235
Biochem J. 1997 Oct 1;327 ( Pt 1):117-23
pubmed: 9355742
J Immunol Methods. 2013 Oct 31;396(1-2):134-9
pubmed: 23994256
Gut. 1999 Jun;44(6):890-5
pubmed: 10323896
Clin Oral Investig. 2012 Dec;16(6):1549-56
pubmed: 22205269
Int Rev Cytol. 2002;213:147-81
pubmed: 11837892
Open Rheumatol J. 2011;5:100-6
pubmed: 22279508
FEBS Lett. 1995 Jan 2;357(1):50-4
pubmed: 8001677
Scand J Clin Lab Invest. 2013 Apr;73(3):193-202
pubmed: 23391285
Ann Rheum Dis. 2005 Sep;64(9):1263-7
pubmed: 15731292
Bull World Health Organ. 2003;81(9):646-56
pubmed: 14710506
Histol Histopathol. 2001 Jan;16(1):319-34
pubmed: 11193208
Int J Mol Sci. 2019 Sep 01;20(17):null
pubmed: 31480518
Microcirculation. 1995 Sep;2(3):217-33
pubmed: 8748946
Cell Mol Life Sci. 2005 Dec;62(24):2939-46
pubmed: 16374582
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Ann Rheum Dis. 2006 Oct;65(10):1261-4
pubmed: 16973787
Nat Rev Rheumatol. 2010 Nov;6(11):625-35
pubmed: 20924410
Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:171-6
pubmed: 15298624